ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0951

Single Cell Analysis of Transitional B Cells in Systemic Sclerosis Highlights Defective Peripheral Tolerance

Claire Beesley1, Nina Goldman1, David Abraham1, Christopher Denton1, Rizgar Mageed2 and Voon Ong3, 1University College London, London, United Kingdom, 2Queen Mary University of London, London, United Kingdom, 3UCL Medical School Royal Free Campus, London, United Kingdom

Meeting: ACR Convergence 2023

Keywords: Autoantibody(ies), autoimmune diseases, B-Lymphocyte, Bioinformatics, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0934–0964) Systemic Sclerosis & Related Disorders – Basic Science Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Transitional B cells comprise a distinct population of B cells that have recently migrated to the periphery from the bone marrow. In systemic sclerosis (SSc),previous data from our laboratory has demonstrated that there are differences in the number and function of transitional B cells compared to healthy controls (HCs). In addition, we have previously isolated transitional B cells from SSc patients which are seropositive for anti-topoisomerase Iautoantibodies (ATA)demonstrating that these cells evade tolerance. To investigate why these autoreactive B cells are not tolerised in those withSSc,we performed a paired bulk and single-cell RNA sequencing study of the transitional B cell subsets in SSc and HCs.

Methods: 5000 CD19+CD24hiCD38hi transitional B cells were sorted from four HCs and four treatmentnaïveATA-positive SSc patients.Single-cell RNA-sequencing was performed on the sorted transitional B cells and the datawas analysed using Seurat in RStudio. Additionally, in a subset of this cohort paired bulk RNA-sequencing of the sorted transitional T1 (CD19+CD24hiCD38hiCD27–IgMhiIgDmed) and T2(CD19+CD24hiCD38hiCD27–IgMhiIgDhi) populations was carried out.

Results: As shown in Figure 1 single cell transcriptomics identified four distinct transitional B cell clusters in SSc patients and HCs. Notably, cluster 1 is diminished in the SSc group and cluster 0 is expanded in SSc compared to HCs. These clusters were characterised using relevant genes as shown in the dotplot in Figure 2. Clusters 0, 1 and 2 all share similar transcriptomic features whilst cluster 3 has upregulated expression of genes associated with commitment to the B cell lineage (EBF1). Thisindicates that cluster 3 is the earliest B cell emigrant from the bone marrow. Clusters 2, 1 and 0 can then be differentiated through expression of genes such as PLD4 and KLF2. Subsequent pathway analyses provided evidence for defective tolerance in SSc patients which may be mediated through dysregulated NF-κB signalling. In addition, differential gene expression analysis using bulk RNA-sequencing of sorted T1 and T2 transitional subsets have identified five candidate gene signatures which are significantly enriched in the T2 cells compared with the T1 cells. This finding was in concordance with the single cell data and provides further evidence to support the existence of a peripheral tolerance/selection checkpoint at the transitional B cell stage.

Conclusion: Through this data we have identified four transitional B cell subsets and have characterised their transcriptomic profile. Additionally, we have found further evidence for a potential breach in tolerance in the SSc patients. Studies are ongoing to explore biological pathways through which altered gene expression impacts peripheral tolerance in SSc.

Supporting image 1

Figure 1. A UMAP plot depicting an integrated scRNA-seq analysis of transitional B cell clusters in 4 healthy controls (HC) and 4 systemic sclerosis (SSc) patients.

Supporting image 2

Figure 2. A dotplot of key genes used to identify transitional B cell clusters in a scRNA-seq study of 4 healthy controls (HC) and 4 systemic sclerosis (SSc) patients.


Disclosures: C. Beesley: Versus Arthritis, 5; N. Goldman: None; D. Abraham: None; C. Denton: AbbVie, 2, Acceleron, 2, Arxx Therapeutics, 5, Bayer, 2, Boehringer-Ingelheim, 2, 6, Corbus, 2, 6, CSL Behring, 2, 5, GlaxoSmithKline, 2, 5, Horizon Therapeutics, 2, Inventiva, 2, 5, Janssen, 6, Roche, 2, Sanofi, 2, Servier, 5; R. Mageed: None; V. Ong: None.

To cite this abstract in AMA style:

Beesley C, Goldman N, Abraham D, Denton C, Mageed R, Ong V. Single Cell Analysis of Transitional B Cells in Systemic Sclerosis Highlights Defective Peripheral Tolerance [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/single-cell-analysis-of-transitional-b-cells-in-systemic-sclerosis-highlights-defective-peripheral-tolerance/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-analysis-of-transitional-b-cells-in-systemic-sclerosis-highlights-defective-peripheral-tolerance/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology